TNFSF15 antibody
Quick Overview for TNFSF15 antibody (ABIN6295967)
Target
See all TNFSF15 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Mouse anti-Human VEGI / TL1A Antibody [Sodium Azide Free]
-
Specificity
- Cytoplasmic, cell surface, secreted
-
Purification
- A full length human recombinant protein was used as the immunogen for this TL1A antibody.
-
Immunogen
- A full length human recombinant protein was used as the immunogen for this TL1A antibody.
-
-
-
-
Application Notes
-
FACS: 0.5-1 μg/10^6 cells
IF: 1-2 μg/mL
Western blot: 1-2 μg/mL
IHC (FFPE): 1-2 μg/mL -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
-
Alternative Name
- Tumor necrosis factor ligand superfamily member 15
-
Background
-
Target Description: TNF ligand-related molecule 1 is an anti-angiogenic cytokine that is also called Tumor necrosis factor superfamily, member 15 (TNFSF15) and Vascular endothelial growth inhibitor (VEGI/VEGI192A). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of TL1A has been reported as a marker of poor prognosis in breast cancer.
Gene Symbol: TNFSF15///TL1///VEGI
-
Gene ID
- 9966
-
UniProt
- O95150
-
Pathways
- Positive Regulation of Endopeptidase Activity, Autophagy
Target
-